Accepted at: Feb, 04, 2025
10:01 a.m.
Author:
alexlewis
Related Deck:
1675118865074
Accepted
Rationale for new note
GOLD Guidelines
Text
GOLD Guidelines
Initial pharmacological treatment for COPD in a patient with moderate or worse symptoms and ≤2 moderate exacerbations yearly, without hospitalisation
{{c1::LABA + LAMA}}
Initial pharmacological treatment for COPD in a patient with moderate or worse symptoms and ≤2 moderate exacerbations yearly, without hospitalisation
{{c1::LABA + LAMA}}
Extra
≥2 moderate exacerbations OR ≥1 leading to hospitalisation |
Group E LABA + LAMA
Consider LABA+LAMA+ICS if eosinophils ≥300μL
|
|
≤2 moderate exacerbations (not leading to hospital admission) |
Group A A bronchodilator |
Group B LABA + LAMA |
mMRC 0-1, CAT <10 | mMRC ≥2, CAT ≥10 |
Personal Notes
Empty field
Missed Questions
Empty field
Oxford Handbook
Empty field
First Aid
Empty field
AMBOSS
Empty field
eTG Complete
Empty field
Talley & O'Connor
Empty field
Additional Resources
Empty field
Source
GOLD 2025 Report Accessed 31 January 2025
One by one
Empty field
Tags
#Malleus_CM::#Guidelines::International::GOLD
#Malleus_CM::#Subjects::Respiratory_Medicine::05_Lungs::01_Obstructive::COPD::08_Diagnosis/Investigations
#Malleus_CM::#Resources_by_Rotation::Internal_Medicine::Respiratory_Medicine
#Malleus_CM::#Resources_by_Rotation::Internal_Medicine::General_Medicine
#Malleus_CM::#Resources_by_Rotation::Emergency
#Malleus_CM::#Resources_by_Rotation::Intensive_Care
#Malleus_CM::#Resources_by_Rotation::Internal_Medicine::Geriatric_Medicine
#Malleus_CM::#Resources_by_Rotation::General_Practice
#Malleus_CM::#Resources_by_Rotation::Internal_Medicine::Cardiology
#Malleus_CM::#Resources_by_Rotation::Internal_Medicine::Palliative_Care
#Malleus_CM::#Yield::High